Immunology

Reviewing new challenges and opportunities for hepatitis B cures

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...

Diseases, Conditions, Syndromes

Examining COVID-19's long-term effects on the innate immune system

The more severe the COVID-19 infection, the slower the recovery of immune cells, such as the dendritic cells, which are necessary for the activation of the immune system. This is shown by researchers at Linköping University ...

Diseases, Conditions, Syndromes

Why do some people get sicker from COVID than others?

COVID-19 vaccines have saved at least a million lives in the United States alone, but for many people, a lingering fear remains: If—or when—they get hit by the coronavirus, just how bad will it be? Will they breeze through ...

page 1 from 6